不安腿综合征如何治疗配图,仅供参考
Common pharmacological agents for the treatment of RLS in clinical practice are DAs,levodopa,Alpha-2-delta calcium channel ligands,opioids,anticonvulsants,benzodiazepines,or drugs acting on adrenergic systems such as clonidine ). In patients with mild or intermittent RLS in which symptoms are not develop daily but are disabling when they are presented,daily treatment is not necessary. We could apply intermittent use of DAs,levodopa (25 mg,one-half or one tablet at bedtime),a benzodiazepine (clonazepam,1-2 mg daily or diazepam) especially in younger patients,or a low-potent opioid and nonpharmacologic therapies ). The clinicians should be cautious about the early morning rebound of symptoms or daytime RLS augmentation by levodopa ). If patients experience disabling and persistent daily symptoms,a DA or an alpha-2-delta calcium channel ligand would be the first line of treatment in addition to nonpharmacologic therapy and iron deficiency treatment ).","department":"